Impact of Antihyperlipidemics on Cardiovascular Diseases: A Comprehensive Review

P. MERCY ANGEL

Keywords: Cardiovascular diseases, antihyperlipidemics, dyslipidemia, statins, cholesterol management

Abstract Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide. Dyslipidemia is a major modifiable risk factor, and antihyperlipidemic agents, including statins, fibrates, and PCSK9 inhibitors, play a pivotal role in reducing cardiovascular risk. This review explores the mechanisms, efficacy, and clinical outcomes of antihyperlipidemic therapy, highlighting recent advances in personalized management of dyslipidemia and its impact on cardiovascular events.

Published Paper   E-Certificate

"Impact of Antihyperlipidemics on Cardiovascular Diseases: A Comprehensive Review", JETNR - JOURNAL OF EMERGING TRENDS AND NOVEL RESEARCH (www.JETNR.org), ISSN:2984-9276, Vol.4, Issue 4, page no.a118-a120, April-2026, Available :https://rjpn.org/JETNR/papers/JETNR2604018.pdf

Volume 4 Issue 4, April-2026

Pages : a118-a120

Paper Reg. ID: JETNR_233569

Published Paper Id: JETNR2604018

Downloads: 00049

Research Area: Humanities All

Country: Hyderabad , Telangana, India

Published Paper PDF: https://rjpn.org/JETNR/papers/JETNR2604018

Published Paper URL: https://rjpn.org/JETNR/viewpaperforall?paper=JETNR2604018

ISSN: 2984-9276 | IMPACT FACTOR: 9.87 Calculated By Google Scholar | ESTD YEAR: 2023

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.87 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: RJPN (IJPublication) Janvi Wave

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition